Impact of 18 F-fl uorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement

Tarec Christoffer El-Galaly, Martin Hutchings, Karen Juul Mylam, Peter de Nully Brown, Anne Bukh, Hans Erik Johnsen, Peter Kamper, Annika Loft, Victor Iyer, Lars Christian Gormsen, Anne Lerberg Nielsen, Martin Bøgsted, Francesco d'Amore

Research output: Contribution to journalJournal articleResearchpeer-review

22 Citations (Scopus)

Abstract

ABSTRACT 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is a highly accurate staging method in classical Hodgkin lymphoma (cHL). We retrospectively compared the staging results obtained in two large cohorts of cHL patients diagnosed before (N=324) and after (N=406) the introduction of PET/CT staging in a retrospective study. In the PET/CT-staged patients, stage I disease was less frequent (16% vs. 27%, P
Original languageEnglish
JournalLeukemia and Lymphoma
Volume55
Issue number10
Pages (from-to)2349-2355
Number of pages7
ISSN1042-8194
DOIs
Publication statusPublished - 2014

Fingerprint

Dive into the research topics of 'Impact of 18 F-fl uorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement'. Together they form a unique fingerprint.

Cite this